CBD in Tonga: not individually verified

Not individually verified

We have not confirmed that CBD specifically is scheduled in Tonga, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record: Not confirmed, and genuinely ambiguous rather than a clean absence. Tetrahydrocannabinol is named on page 21 of Schedule 1, and Schedule 1's opening paragraph extends control to a named drug's isomers without defining the word. Cannabidiol shares tetrahydrocannabinol's molecular formula, C21H30O2, and the two are commonly described as structural isomers because both derive from the same cannabis biosynthetic precursor. But cannabidiol does not share tetrahydrocannabinol's ring skeleton the way delta-8-THC does: tetrahydrocannabinol is tricyclic, with a closed pyran ring joining the terpene ring to the resorcinol ring through an oxygen bridge, while cannabidiol is bicyclic, with that ring open and a free phenolic hydroxyl instead of the ether bridge. Converting cannabidiol to tetrahydrocannabinol requires forming that ring, not merely moving a double bond within an existing shared skeleton. Whether an undefined 'isomer' in a 2003 schedule was meant to reach a same-formula compound with a different ring count, rather than only a positional or stereochemical isomer of the identical skeleton, is not settled by the instrument's text, and no case law or regulation construing the word was located.

Confirm directly with Tonga’s national drug authority or your own embassy before you rely on anything.

What Tonga HAS confirmed for related substances

Cannabis / THCa related compound, not CBD
Named. Schedule 1 (section 2) of the Illicit Drugs Control Act, Act 7 of 2003, Cap. 4.06, 2020 Revised Edition, lists cannabis under its own «CLASS B12» heading, which the Act's own endnote records as inserted by Act 18 of 2012, reading in full, with the Schedule's own dash between the parenthetical and its clarifying clause rendered here as a comma per house style: «Cannabis and Cannabis resin. Cannabis fruit. Cannabis plant (whether fresh, dried, or otherwise), that is, any part of any plant of the genus cannabis. Cannabis seed. Cannabis oil.» Cannabis is therefore a Class B drug, the only Class B entry in the whole of Schedule 1; every other named substance in the Schedule sits under the earlier «CLASS A» heading. Two later amendment Acts, the Illicit Drugs Control (Amendment) (No.1) Act 2024 and the Illicit Drugs Control (Amendment) (No.2) Act 2024, could not be retrieved this session, both the direct PDF link and the containing legislation index returned HTTP 404, so whether either amended this Schedule 1 entry is not verified, not ruled out.
ago.gov.to · ago.gov.to · ago.gov.to · https://ago.gov.to/cms/images/LEGISLATION/AMENDING/2025/2025-0026/IllicitDrugsControlAmendmentNo1Act2024.pdf (returned HTTP 404, not retrieved) · https://ago.gov.to/cms/images/LEGISLATION/AMENDING/2025/2025-0027/IllicitDrugsControlAmendmentNo2Act2024.pdf (returned HTTP 404, not retrieved) · ago.gov.to · ago.gov.to · ago.gov.to · Verified October 8, 2026
Delta-8-THCa related compound, not CBD
Caught by Schedule 1's own isomer clause, not by name. Tetrahydrocannabinol is named directly on page 21 of the Illicit Drugs Control Act's Schedule 1, in the Class A list drawn from Schedule I of the Convention on Psychotropic Substances, 1971. Schedule 1's opening paragraph extends control to the named drugs' isomers without qualifying the term: drugs designated by their international non-proprietary names, 'their isomers, esters and ethers, their salts, including the salts of any such isomer, ester or ether, and any preparations including any such substances, are illicit drugs unless exempted by law'. Delta-8-THC and the tetrahydrocannabinol named in Schedule 1 (conventionally delta-9-THC) share the same molecular formula and the same tricyclic dibenzopyran ring skeleton; they differ only in the position of one ring double bond, carbon 8 to carbon 9 against carbon 9 to carbon 10, which is the textbook definition of a positional isomer of the same parent molecule. That is a different and stronger case than the other isolated cannabinoids checked for this country, which do not share tetrahydrocannabinol's ring skeleton.
Illicit Drugs Control Act, Act 7 of 2003, Cap. 4.06, 2020 Revised Edition, Schedule 1 page 21, sections 2, 3, 4 and 7 · https://ago.gov.to/cms/images/LEGISLATION/PRINCIPAL/2003/2003-0007/IllicitDrugsControlAct_3.pdf | Illicit Drugs Control (Amendment) Act 2020, Act 15 of 2020, sections 2, 3 and 4 · https://ago.gov.to/cms/images/LEGISLATION/AMENDING/2020/2020-0123/IllicitDrugsControlAmendmentAct2020.pdf | Illicit Drugs Control (Amendment) Act 2021, Act 19 of 2021, section 3 · https://ago.gov.to/cms/images/LEGISLATION/AMENDING/2021/2021-0050/IllicitDrugsControlAmendmentAct2021.pdf | Illicit Drugs Control (Amendment) (No.1) and (No.2) Act 2024, indexed but not retrievable · ago.gov.to · ago.gov.to · Verified October 8, 2026
Synthetic Cannabinoids (K2 / Spice)a related compound, not CBD
Synthetic cannabinoids are a heterogeneous class of synthetic cannabinoid receptor agonists, JWH-018 and AM-2201 among the better known, rather than one compound, and the finding below answers for the class as a whole, since no individual member of it is named in the instruments read. None is named in Schedule 1 of the Illicit Drugs Control Act. The only cannabinoid-class entry in Schedule 1 is tetrahydrocannabinol, which carries a dibenzopyran ring skeleton with a pentyl or related alkyl side chain; most synthetic cannabinoid receptor agonists are built on a wholly different core, typically an indole or indazole ring joined to a naphthoyl, adamantoyl or similar group, sharing no ring system, functional group or homologous side chain with tetrahydrocannabinol. The Illicit Drugs Control (Amendment) Act 2020 analogue clause's three structure-modification routes, functional-group replacement, ring-structure replacement and hydrogenation, and its homologue limb, all require a stated relationship to a named parent, and the core-skeleton difference between an indole and a dibenzopyran means that relationship could not be established for the class as a whole.
Illicit Drugs Control Act, Act 7 of 2003, Cap. 4.06, 2020 Revised Edition, Schedule 1 and Schedule 2 · https://ago.gov.to/cms/images/LEGISLATION/PRINCIPAL/2003/2003-0007/IllicitDrugsControlAct_3.pdf | Illicit Drugs Control (Amendment) Act 2020, Act 15 of 2020, section 2 · https://ago.gov.to/cms/images/LEGISLATION/AMENDING/2020/2020-0123/IllicitDrugsControlAmendmentAct2020.pdf | Illicit Drugs Control (Amendment) Act 2021, Act 19 of 2021 · https://ago.gov.to/cms/images/LEGISLATION/AMENDING/2021/2021-0050/IllicitDrugsControlAmendmentAct2021.pdf | Illicit Drugs Control (Amendment) (No.1) and (No.2) Act 2024, indexed but not retrievable · ago.gov.to · ago.gov.to · Verified October 8, 2026

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.

Before you travel

Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.

If you’re detained or arrested abroad

Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →

← CBD in every country All substances in Tonga